• Introduced
    Nov 21, 2025
  • Passed Senate
    Feb 24, 2026
  • Passed House
  • Became Law
SB 465
New Hampshire Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Title: classifying xylazine as a schedule III controlled drug.
Last Action See all actions
House • Mar 18, 2026: Public Hearing: 03/31/2026 01:30 pm GP 153
Mar 31, 2026 10:00am
GP, Room 153

Summary

Comments on SB 465

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Mar 18, 2026 | House
    • Public Hearing: 03/31/2026 01:30 pm GP 153
  • Mar 16, 2026 | House
    • Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8
  • Feb 24, 2026 | Senate
    • Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5
  • Feb 05, 2026 | Senate
    • Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A
    • Committee Report: Ought to Pass with Amendment #2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8
    • Committee Amendment #2026-0842s, AA, VV; 03/05/2026; SJ 5
  • Nov 21, 2025 | Senate
    • Introduced 01/07/2026 and Referred to Judiciary; SJ 1